Triptolide Promotes Ferroptosis in Cervical Cancer Cell via NRF2 / xCT / GPX4
Phytotherapy Research · 2025
DOI: 10.1002/ptr.8398 ↗At a glance
Journal article in Phytotherapy Research, 2025. Written by Miaomiao Feng and 4 co-authors. Institution: Department of Gynaecology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China. Major MEDLINE topics: Ferroptosis, NF-E2-Related Factor 2, Phenanthrenes, Diterpenes. Cited 21 times so far (Crossref); 31 references. Funded by: Traditional Chinese Medicine of bureau of Guangdong Province.
Abstract (original language)
Cervical cancer (CC) is a serious risk to women's health; it is necessary to explore less toxic and more effective therapies to cure CC. Triptolide (Tri) is the principal active constituent found in “Tripterygium Wilford,” has been shown to have antitumor effects. This study set up to demonstrate whether Tri is capable of inducing ferroptosis in CC cells and its potential mechanism. In vitro, Tri was used to treat CC cells, and lipid peroxidation levels in CC cells were detected by flow cytometry, immunofluorescence, and other experiments; the molecular mechanism of Tri treatment of CC was explored by western blot; moreover, the regulatory effects of Tri on the NRF2/GPX4/xCT axis were verified by overexpressing NRF2 in reverse. In vivo, CC cells tumor‐bearing mice were constructed to observe the effect of Tri treatment on tumor growth. In vitro, we have demonstrated that Tri prevents the growth and migration of CC cells. Further investigation revealed that Tri substantially enhances ferroptosis in CC cells by increasing lipid peroxidation accumulation. Mechanically, Tri significantly reduced the expression of NRF2, leading to a corresponding repression of the NRF2 downstream targets GPX4 and xCT. Moreover, overexpressing of NRF2 effectively reversed the impact of Tri on ferroptosis in CC cells. Additionally, animal experiments indicted that Tri markedly inhibited tumor size in nude mice by inhibiting the NRF2/GPX4/xCT axis. Tri exerts antitumor effects by triggering ferroptosis in CC cells through the NRF2/GPX4/xCT axis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Gynaecology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
- The First Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
ORCID profiles: Miaomiao Feng
Funding
- Traditional Chinese Medicine of bureau of Guangdong Province
Cite
APA
Feng, M., Wu, H., Zhu, L., Gao, J., & Deng, G. (2025). Triptolide Promotes Ferroptosis in Cervical Cancer Cell via NRF2 / xCT / GPX4. Phytotherapy Research. https://doi.org/10.1002/ptr.8398
Vancouver
Feng M, Wu H, Zhu L, Gao J, Deng G. Triptolide Promotes Ferroptosis in Cervical Cancer Cell via NRF2 / xCT / GPX4. Phytotherapy Research. 2025. doi:10.1002/ptr.8398
BibTeX
@article{Feng2025,
author = {Feng, Miaomiao and Wu, Haiwang and Zhu, Ling and Gao, Jie and Deng, Gaopi},
title = {Triptolide Promotes Ferroptosis in Cervical Cancer Cell via NRF2 / xCT / GPX4},
journal = {Phytotherapy Research},
year = {2025},
doi = {10.1002/ptr.8398}
}
EUVIMED